These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 12591924)
1. Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis. Raja SM; Chhablani N; Swanson R; Thompson E; Laffan M; Lane DA; Olson ST J Biol Chem; 2003 Apr; 278(16):13688-95. PubMed ID: 12591924 [TBL] [Abstract][Full Text] [Related]
2. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation. Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262 [TBL] [Abstract][Full Text] [Related]
3. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin. Chuang YJ; Swanson R; Raja SM; Olson ST J Biol Chem; 2001 May; 276(18):14961-71. PubMed ID: 11278930 [TBL] [Abstract][Full Text] [Related]
4. Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes. Futamura A; Beechem JM; Gettins PG Biochemistry; 2001 Jun; 40(22):6680-7. PubMed ID: 11380263 [TBL] [Abstract][Full Text] [Related]
5. The role of Arg46 and Arg47 of antithrombin in heparin binding. Arocas V; Bock SC; Olson ST; Björk I Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728 [TBL] [Abstract][Full Text] [Related]
6. Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin. Izaguirre G; Swanson R; Raja SM; Rezaie AR; Olson ST J Biol Chem; 2007 Nov; 282(46):33609-33622. PubMed ID: 17875649 [TBL] [Abstract][Full Text] [Related]
7. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor. Björk I; Ylinenjärvi K; Olson ST; Bock PE J Biol Chem; 1992 Jan; 267(3):1976-82. PubMed ID: 1730729 [TBL] [Abstract][Full Text] [Related]
8. Role of arginine 129 in heparin binding and activation of antithrombin. Desai U; Swanson R; Bock SC; Bjork I; Olson ST J Biol Chem; 2000 Jun; 275(25):18976-84. PubMed ID: 10764763 [TBL] [Abstract][Full Text] [Related]
9. Kinetic characterization of the proteinase binding defect in a reactive site variant of the serpin, antithrombin. Role of the P1' residue in transition-state stabilization of antithrombin-proteinase complex formation. Olson ST; Stephens AW; Hirs CH; Bock PE; Björk I J Biol Chem; 1995 Apr; 270(17):9717-24. PubMed ID: 7730349 [TBL] [Abstract][Full Text] [Related]
10. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis. Rosenberg RD Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697 [TBL] [Abstract][Full Text] [Related]
11. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758 [TBL] [Abstract][Full Text] [Related]
12. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants. Fan B; Turko IV; Gettins PG Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827 [TBL] [Abstract][Full Text] [Related]
13. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies. Rezaie AR; Olson ST Biochemistry; 2000 Oct; 39(39):12083-90. PubMed ID: 11009624 [TBL] [Abstract][Full Text] [Related]
15. Importance of the P2 glycine of antithrombin in target proteinase specificity, heparin activation, and the efficiency of proteinase trapping as revealed by a P2 Gly --> Pro mutation. Chuang YJ; Gettins PG; Olson ST J Biol Chem; 1999 Oct; 274(40):28142-9. PubMed ID: 10497166 [TBL] [Abstract][Full Text] [Related]
16. Antithrombin conformational modulation by D-myo-inositol 3,4,5,6-tetrakisphosphate (TMI), a novel scaffold for the development of antithrombotic agents. Arantes PR; Pérez-Sánchez H; Verli H J Biomol Struct Dyn; 2018 Nov; 36(15):4045-4056. PubMed ID: 29173042 [TBL] [Abstract][Full Text] [Related]
17. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis. Lane DA; Lowe GD; Flynn A; Thompson E; Ireland H; Erdjument H Br J Haematol; 1987 Aug; 66(4):523-7. PubMed ID: 3663509 [TBL] [Abstract][Full Text] [Related]
18. Role of the C-sheet in the maturation of N-glycans on antithrombin: functional relevance of pleiotropic mutations. Aguila S; Navarro-Fernández J; Bohdan N; Gutiérrez-Gallego R; de la Morena-Barrio ME; Vicente V; Corral J; Martínez-Martínez I J Thromb Haemost; 2014 Jul; 12(7):1131-40. PubMed ID: 24824609 [TBL] [Abstract][Full Text] [Related]
19. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin. Okajima K; Abe H; Wagatsuma M; Okabe H; Takatsuki K Am J Hematol; 1995 Jan; 48(1):12-8. PubMed ID: 7832187 [TBL] [Abstract][Full Text] [Related]
20. Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin. Ireland H; Lane DA; Thompson E; Walker ID; Blench I; Morris HR; Freyssinet JM; Grunebaum L; Olds R; Thein SL Br J Haematol; 1991 Sep; 79(1):70-4. PubMed ID: 1911389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]